Compagnie Lombard Odier S Cm A Idera Pharmaceuticals, Inc. Transaction History

Compagnie Lombard Odier S Cm A

  • $5.66 Billion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 13, 2019
SELL
$2.77 - $9.38 $38,087 - $128,975
-13,750 Closed
0 $0
Q3 2018

Nov 13, 2018
BUY
$5.53 - $11.36 $76,037 - $156,200
13,750 New
13,750 $123,000

Others Institutions Holding IDRA

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About IDERA PHARMACEUTICALS, INC.

IDRA Quotes by TradingView
  • Ticker IDRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,296,900
  • Market Cap $188M
  • Description
  • Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating s...
More about IDRA
Track This Portfolio

Track Compagnie Lombard Odier S Cm A Portfolio

Follow Compagnie Lombard Odier S Cm A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Compagnie Lombard Odier S Cm A, based on Form 13F filings with the SEC.

News

Stay updated on Compagnie Lombard Odier S Cm A with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email